TY - JOUR T1 - Dual-Targeted Molecular Imaging of Cancer JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 390 LP - 395 DO - 10.2967/jnumed.117.199877 VL - 59 IS - 3 AU - Emily B. Ehlerding AU - Lingyi Sun AU - Xiaoli Lan AU - Dexing Zeng AU - Weibo Cai Y1 - 2018/03/01 UR - http://jnm.snmjournals.org/content/59/3/390.abstract N2 - Molecular imaging is critical to personalized and precision medicine. Although singly targeted imaging probes are making an impact both clinically and preclinically, molecular imaging strategies using bispecific probes have enabled improved visualization of cancer in recent years through synergistic targeting of two ligands. In this Focus on Molecular Imaging review, we outline how peptide-, antibody-, and nanoparticle-based platforms have affected this emerging strategy, providing examples and pointing out areas in which the greatest clinical impact may be realized. ER -